Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Neurochemical pathology of dementia

View through CrossRef
This chapter considers the neurodegenerative disorders Alzheimer’s disease (AD), Lewy body dementias (dementia with Lewy bodies (DLB) and Parkinson’s disease dementia(PDD)), frontotemporal dementia (FTD); and also vascular dementia (VaD) which results from cerebrovascular disease. These different conditions, which give rise to dementia syndromes, each have distinct neurochemical pathologies, with important implications for treatment. As increased age is the common risk factor generally associated with dementing illnesses, neurochemical changes are set in the context of the changes which occur during ageing. A detailed understanding of the neurotransmitter function in each condition can lead to rational drug design and treatment strategies appropriate for each group of patients. Neurochemical pathology in transmitter systems underlying clinical features of these disorders are reviewed.
Title: Neurochemical pathology of dementia
Description:
This chapter considers the neurodegenerative disorders Alzheimer’s disease (AD), Lewy body dementias (dementia with Lewy bodies (DLB) and Parkinson’s disease dementia(PDD)), frontotemporal dementia (FTD); and also vascular dementia (VaD) which results from cerebrovascular disease.
These different conditions, which give rise to dementia syndromes, each have distinct neurochemical pathologies, with important implications for treatment.
As increased age is the common risk factor generally associated with dementing illnesses, neurochemical changes are set in the context of the changes which occur during ageing.
A detailed understanding of the neurotransmitter function in each condition can lead to rational drug design and treatment strategies appropriate for each group of patients.
Neurochemical pathology in transmitter systems underlying clinical features of these disorders are reviewed.

Related Results

Dementia 1: Defining Dementia, Alzheimer’s Disease and Frontotemporal Dementia (DRAFT)
Dementia 1: Defining Dementia, Alzheimer’s Disease and Frontotemporal Dementia (DRAFT)
The video in this chapter explores dementia, and focuses on definitions of dementia, Alzheimer’s disease and Frontotemporal Dementia. Dementia is defined as a cognitive decline in ...
Management of dementia
Management of dementia
The management of dementia discusses the needs of people in both the early and later stages of dementia, focusing on social and environmental aspects as well as physical and psycho...
Dementia
Dementia
This three-volume collection of essays provides a comprehensive review of state-of-the-art clinical phenomenology, mechanisms, and treatment strategies for the major dementias—part...
Frontotemporal dementia
Frontotemporal dementia
Frontotemporal dementia (FTD) is the second most common form of dementia in persons younger than 65 years after Alzheimer’s disease. The FTD spectrum is characterized by clinical, ...
Dementia
Dementia
This three-volume collection of essays provides a comprehensive review of state-of-the-art clinical phenomenology, mechanisms, and treatment strategies for the major dementias—part...
Dementia
Dementia
This three-volume collection of essays provides a comprehensive review of state-of-the-art clinical phenomenology, mechanisms, and treatment strategies for the major dementias—part...
Diagnosis and Therapy for Lewy Body Dementia
Diagnosis and Therapy for Lewy Body Dementia
Almost undistinguished some 30 years ago, dementia with Lewy bodies is now shown to be the second most common neurodegenerative cause of dementia in the elderly. A host of neuroinf...
Molecular genetics and biology of dementia
Molecular genetics and biology of dementia
Considerable progress has been made in our understanding of the genetics and molecular biology of dementia. In this chapter we focus predominantly on the most common form of dement...

Back to Top